This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
Genomic Biomarker Testing
PEACE-3 Trial
PROfound Trial
PSMAfore Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
BOND-003 Cohort P
CORE-001 Study
CORE-008
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Daniel D. Joyce, MD, MS
Bladder Cancer
Non-Muscle Invasive Bladder Cancer
Ashish Kamat, MD
Muscle-Invasive Bladder Cancer
Advanced & Metastatic Bladder Cancer (mUC)
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher® Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
mCRPC with Bone Metastasis
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
Testicular, Penile & Rare GU Malignances
Testicular Cancer
Functional Urology
Functional Urology
Alan J. Wein, MD, PhD (hon.)
Urologic Catheters - CAUTI Challenges
Videos
Exclusives
Conferences
Disparities: Social Determinants of Health
Exclusive Collaborations
Health Policy in Urological Diseases
Independent Medical Education
Journal Clubs
Practice Guidelines Reviews
The Prostate Cancer Foundation
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Functional Urology
Men's Health
Pelvic Health
Actionable Clinical Data
Bladder Cancer
NMIBC with CIS: Evidence, Practice & Emerging Research
Risk-Stratified NMIBC Management
Trials in Progress
Prostate Cancer
Localized Prostate Cancer
CLARIFY
ESCAPE
FORT
NRG-GU 0101
RTIRE
High Risk BCR HSPC
ARASTEP
Oligometastatic Prostate Cancer
METANOVA
mHSPC
ARASEC
ASPIRE
MEVPRO-3
mCRPC
ECLIPSE
LEGION-100
MEVPRO-1 & 2
PROMISE
SECuRE
Bladder Cancer
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SNMMI 2026
ASCO 2026
AUA 2026
APCCC 2026
PSMA and Beyond 2026
All Conferences
View All
PCF
UroToday Home
Conference Highlights
CUA 2018
CUA 2018
Prostate Cancer
Bladder Cancer
Kidney Cancer
Testicular Cancer
Stone Disease
Minimally Invasive Procedures
Lower Urinary Tract Symptoms
Leadership, Communication and Practice Management
CUA 2018 Prostate Cancer
Viewing 1-20 of 33 articles
CUA 2018: Risk Factors for Deviation of Preoperative Planned Neurovascular Bundle Preservation During Robotic Radical Prostatectomy
CUA 2018: Incorporating Measures of Patient Safety into Technical Skill Assessments in Robotic Assisted Radical Prostatectomy
CUA 2018: Quantifying the “Assistant Effect” in Robotic-Assisted Radical Prostatectomy: Measures of Technical Performance
CUA 2018: Functional Outcomes And Post-Operative Complications In Elderly Patients Undergoing Robotic-Assisted Radical Prostatectomy
CUA 2018: Impact Of The Rocco Stitch On Early Return To Continence Following Robot-Assisted Radical Prostatectomy: Results Of A Prospective, Longitudinal, Randomized Controlled Trial
CUA 2018: An Educational Intervention for Androgen Deprivation Therapy Patients: Dyadic Adjustment and Intimacy Outcomes
CUA 2018: Validation of the 2015 Prostate Cancer Gleason Grade Groups for Predicting Cancer Control Outcomes after Radical Prostatectomy
CUA 2018: Robotic vs. Open Prostatectomy: A Real-World, Single-Centre Canadian Experience
CUA 2018: Factors Associated with Usage of Bone-Targeted Therapies in Metastatic Castration-Resistant Prostate Cancer
CUA 2018: Disparity in Public Funding of Therapies for Metastatic Castrate-Resistant Prostate Cancer Across Canadian Provinces
CUA 2018: Educational Needs of Canadian Physicians in the Management of Advanced Prostate Cancer
CUA 2018: The Opioid Epidemic and Testosterone Dysfunction – Current Challenges and a Future Roadmap for the Practicing Clinician
CUA 2018: The WATER Study Clinical Results: A Subgroup Analysis of Larger Prostates from the Phase 3, Blinded, Randomized Trial of Aquablation vs. Transurethral Resection of the Prostate
CUA 2018: Do Common Urological Procedures Increase the Risk of an Infected Joint Prosthesis?
CUA 2018: The Early Canadian Experience with ATOMS for Post–Prostatectomy Incontinence
CUA 2018: Efficacy and Tolerability of First-Line Abiraterone + Prednisone vs. Enzalutamide for Metastatic Castration-Resistant Prostate Cancer in Men ≥80 Years: A Retrospective Study
CUA 2018: Evolving Approaches in Diagnosing Prostate Cancer: Beyond PSA
CUA 2018: Development of a Management Algorithm for Prostate Cancer Patients with a Biochemical Recurrence after Radical Therapy
CUA 2018: A Quantitative Assessment of Residual Confounding in the Comparison Between Surgery and Radiotherapy in the Treatment of Non-Metastatic Prostate Cancer
CUA 2018: Real-World Evidence in Patient-Related Outcomes of Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Abiraterone Acetate Plus Prednisone
1
2
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free